Abstract

In response to the opioid crisis, IDSA and HIVMA established a working group to drive an evidence- and human rights-based response to illicit drug use and associated infectious diseases. Infectious diseases and HIV physicians have an opportunity to intervene, addressing both conditions. IDSA and HIVMA have developed a policy agenda highlighting evidence-based practices that need further dissemination. This paper reviews (1) programs most relevant to infectious diseases in the 2018 SUPPORT Act; (2) opportunities offered by the “End the HIV Epidemic” initiative; and (3) policy changes necessary to affect the trajectory of the opioid epidemic and associated infections. Issues addressed include leveraging harm reduction tools and improving integrated prevention and treatment services for the infectious diseases and substance use disorder care continuum. By strengthening collaborations between infectious diseases and addiction specialists, including increasing training in substance use disorder treatment among infectious diseases and addiction specialists, we can decrease morbidity and mortality associated with these overlapping epidemics.

中文翻译：

---

需要采取联邦和州行动来结束美国非法药物使用的感染并发症：IDSA 和 HIVMA 的倡导议程。

摘要

为了应对阿片类药物危机，IDSA 和 HIVMA 成立了一个工作组，以推动对非法药物使用和相关传染病采取基于证据和人权的应对措施。传染病和艾滋病毒医生有机会进行干预，解决这两种情况。IDSA 和 HIVMA 制定了政策议程，强调需要进一步传播的循证实践。本文回顾了 (1) 2018 年支持法案中与传染病最相关的项目；（2）“终结艾滋病流行”倡议提供的机遇；(3) 影响阿片类药物流行及相关感染轨迹所需的政策变化。解决的问题包括利用减少伤害工具和改进传染病和药物滥用障碍护理连续体的综合预防和治疗服务。通过加强传染病和成瘾专家之间的合作，包括加强传染病和成瘾专家之间物质使用障碍治疗的培训，我们可以降低与这些重叠流行病相关的发病率和死亡率。